215 related articles for article (PubMed ID: 6607481)
1. Imaging local brain function with emission computed tomography.
Kuhl DE
Radiology; 1984 Mar; 150(3):625-31. PubMed ID: 6607481
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging of regional cerebral glucose metabolism.
Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
[TBL] [Abstract][Full Text] [Related]
3. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3.
Kuhl DE; Engel J; Phelps ME; Selin C
Ann Neurol; 1980 Oct; 8(4):348-60. PubMed ID: 6776878
[TBL] [Abstract][Full Text] [Related]
4. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
[TBL] [Abstract][Full Text] [Related]
5. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
Kuhl DE; Metter EJ; Riege WH
Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
Kuhl DE; Metter EJ; Riege WH
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():211-26. PubMed ID: 4023401
[TBL] [Abstract][Full Text] [Related]
7. Cerebral metabolism of glucose in benign hereditary chorea.
Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
[TBL] [Abstract][Full Text] [Related]
8. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
[TBL] [Abstract][Full Text] [Related]
9. Quantifying interictal metabolic activity in human temporal lobe epilepsy.
Henry TR; Mazziotta JC; Engel J; Christenson PD; Zhang JX; Phelps ME; Kuhl DE
J Cereb Blood Flow Metab; 1990 Sep; 10(5):748-57. PubMed ID: 2384546
[TBL] [Abstract][Full Text] [Related]
10. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
Okada J; Peppard R; Calne DB
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
[TBL] [Abstract][Full Text] [Related]
11. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.
Kuhl DE; Metter EJ; Riege WH; Phelps ME
J Cereb Blood Flow Metab; 1982; 2(2):163-71. PubMed ID: 6978885
[TBL] [Abstract][Full Text] [Related]
12. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
13. Single-scan Bayes estimation of cerebral glucose metabolic rate: comparison with non-Bayes single-scan methods using FDG PET scans in stroke.
Wilson PD; Huang SC; Hawkins RA
J Cereb Blood Flow Metab; 1988 Jun; 8(3):418-25. PubMed ID: 3259241
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy.
Abou-Khalil BW; Siegel GJ; Sackellares JC; Gilman S; Hichwa R; Marshall R
Ann Neurol; 1987 Oct; 22(4):480-6. PubMed ID: 3124709
[TBL] [Abstract][Full Text] [Related]
15. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
[TBL] [Abstract][Full Text] [Related]
16. A double FDG/PET study of the effects of scopolamine in older adults.
Molchan SE; Matochik JA; Zametkin AJ; Szymanski HV; Cantillon M; Cohen RM; Sunderland T
Neuropsychopharmacology; 1994 May; 10(3):191-8. PubMed ID: 7916916
[TBL] [Abstract][Full Text] [Related]
17. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
Arahata Y; Kato T; Tadokoro M; Sobue G
Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
[TBL] [Abstract][Full Text] [Related]
18. The use and impact of positron computed tomography scanning in epilepsy.
Mazziotta JC; Engel J
Epilepsia; 1984; 25 Suppl 2():S86-104. PubMed ID: 6430693
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects.
Pawlik G; Wienhard K; Herholz K; Wagner R; Heiss WD
Prog Brain Res; 1984; 62():253-62. PubMed ID: 6335919
[No Abstract] [Full Text] [Related]
20. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
Kling AS; Metter EJ; Riege WH; Kuhl DE
Am J Psychiatry; 1986 Feb; 143(2):175-80. PubMed ID: 3946650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
